Investing.com -- Neuraxis Inc (NASDAQ:NRIX) stock gained 4.2% in premarket trading Friday after the company received FDA clearance for its nerve stimulation technology to treat functional abdominal ...
Achieves significant expansion of NeurAxis’ total addressable marketClearance now includes patients aged “8 years and older”Expanded age ...
Medical Device Network on MSN
FDA clears NeurAxis’ neurostimulator for abdominal pain
The expanded FDA clearance makes NeurAxis’ IB-Stim the first FDA approval for a treatment that specifically addresses ...
Achieves significant expansion of NeurAxis' total addressable market Clearance now includes patients aged“8 years and older” Expanded age indication will utilize the upcoming January 1 st, 2026, ...
A secondary analysis on a randomized trial exploring how tailored cognitive-behavioral therapy affects health care utilization in pediatric functional abdominal pain disorder.
Many of the cases of colon cancer present early symptoms similar to those of IBS, or irritable bowel syndrome, since both ...
Digestive woes like bloating and cramps often lead to confusion between IBS and IBD. While IBS is a functional disorder ...
Health on MSN
5 Supplements That Can Improve Bloating Naturally
Supplements like probiotics, prebiotics, digestive enzymes, and peppermint oil can help with bloating by improving overall gut health and digestion.
The FDA expands use of linaclotide to children as young as age 7 years with irritable bowel syndrome with constipation (IBS-C ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback